Veterinary Referral Center of Central Oregon Expands Life-Saving Treatment Options With Extracorporeal Therapies
BEND, OR / ACCESS Newswire / August 12, 2025 / The Veterinary Referral Center of Central Oregon (VRCCO) is proud to announce the addition of advanced Extracorporeal Therapies, including Hemodialysis, Therapeutic Plasma Exchange, and Hemoperfusion, to its suite of specialized veterinary services. VRCCO is honored to be among the few facilities in the US to offer these cutting-edge treatments that provide new hope for pets suffering from acute kidney injuries, chronic kidney disease, immune-mediated diseases, and life-threatening toxicities.
Hemodialysis serves as an "artificial kidney" by filtering a pet's blood to remove harmful substances such as waste, toxins, and excess fluids. While it does not directly heal the kidneys, it provides a vital window of time for recovery, while significantly improving comfort and quality of life for the pet during this critical period. Hemodialysis is most commonly used for acute kidney injuries, severe electrolyte imbalances, fluid overload, and certain toxicities.
Therapeutic Plasma Exchange (TPE) is a procedure designed to remove harmful substances from a pet's plasma, replacing it with donor plasma. This therapy is particularly effective in managing severe immune-mediated conditions such as immune-mediated hemolytic anemia (IMHA) and myasthenia gravis, as well as certain toxicities. Pets may experience rapid improvement, particularly with immune-mediated diseases that are unresponsive to conventional treatments.
Hemoperfusion involves filtering a pet's blood through a cartridge containing activated charcoal or similar materials to adsorb toxins. This technique is especially valuable in cases of NSAID overdoses (e.g., ibuprofen, carprofen) or exposure to other harmful substances where no antidote exists. Treatments are generally completed within 2-4 hours, and a single session is often sufficient if administered before organ damage occurs.
VRCCO utilizes the same advanced dialysis machines and materials used in human medicine, ensuring the highest standards of care. Throughout treatments, patients are continuously monitored for vital parameters including blood clotting times, fluid balance, hematocrit, electrolytes, and cardiac health, with personalized attention from their care team. Pet Parents should also be aware of the following while considering these therapies:
Comfort & Compassionate Care: Dialysis treatments are not painful. Pets rest comfortably on soft bedding under the continuous care and observation of VRCCO's specialized team. Sedation is rarely required.Patient Size & Suitability: Most companion animals, regardless of size, can be safely treated. VRCCO's in-house blood bank ensures the availability of transfusions if necessary.Prognosis & Expectations: Treatment outcomes are highly variable and depend on the severity and cause of the condition. Some pets may require only a few treatments, while others may need ongoing therapy.Early Intervention is Critical: Starting dialysis before severe complications arise, such as fluid overload or organ dysfunction, dramatically improves the likelihood of a positive outcome.
The Veterinary Referral Center's board-certified specialists encourage pet parents and referring veterinarians to consult with them to determine whether these therapies are appropriate for individual cases. In many situations, time is a critical factor and early intervention can be life-saving. To learn more about Extracorporeal Therapies or VRCCO's comprehensive specialty services, please contact the Veterinary Referral Center of Central Oregon at 541-209-6960 or info@vrcvet.com.
Contact Information
Katie Sedivec Marketing Directormarketing@vrcvet.com541-209-6960
SOURCE: Veterinary Referral Center of Central Oregon
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Alligator Bioscience to Host Virtual R&D Day on 19 August 2025
LUND, SE / / August 14, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announces that it will host a virtual R&D Day on Tuesday, 19 August 2025 at 4 p.m. CEST. The event will provide an in-depth update on Alligator's R&D pipeline, with a primary focus on its lead candidate mitazalimab, ahead of the upcoming TO 13 warrant exercise period (1-15 September 2025). During the event, members of Alligator's executive management and R&D leadership will: Provide update on mitazalimab clinical data, as well biomarker findings and Phase 3 readiness. Discuss ongoing and planned investigator-initiated trials (IITs) exploring mitazalimab in additional indications and clinical settings. Provide a brief update on the pipeline program HLX22. Outline key R&D milestones over the next 6-12 months. The R&D Day will be held as a live Teams webinar and will include a Q&A session. All participants will have the opportunity to submit questions in advance, via ir@ or during the event. Event detailsDate: Tuesday, 19 August 2025Time: 4-5 p.m. CESTFormat: Virtual Teams webinarRegistration: Please use this link to register A replay of the event will be made available on Alligator's website after the webinar. For further information, please contact: Søren Bregenholt, CEOE-mail: +46 (0) 46 540 82 00 The information was submitted for publication, through the agency of the contact person set out above, at 1:00 p.m. CEST on 14 August 2025. About Alligator Bioscience Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. This validated approach promotes priming of tumor-specific T cells and reversing the immunosuppressive nature of the tumor microenvironment, with significant potential benefits for cancer patients across multiple types of cancer. The Company's lead drug candidate mitazalimab is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 24-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1. Alligator is listed on Nasdaq Stockholm (ATORX) and headquartered in Lund, Sweden. For more information, please visit Attachments Alligator Bioscience to host virtual R&D Day on 19 August 2025 SOURCE: Alligator Bioscience View the original press release on ACCESS Newswire Sign in to access your portfolio
Miami Herald
4 hours ago
- Miami Herald
Choice Health Centre Recognized for Excellence in Health & Wellness Services in Halifax
HALIFAX, NS / ACCESS Newswire / August 14, 2025 / Choice Health Centre, a leader in collaborative healthcare in Halifax, has been selected as a 2025 Consumer Choice Award recipient in the category of Health & Wellness for the Halifax Greater Region. This recognition reflects the company's ongoing commitment to delivering the highest quality collaborative, patient-directed care that supports long-term health and wellness. Collaborative, Integrated Health Care in Halifax At the core of the Centre's model is a team of carefully selected healthcare professionals providing services such as Physiotherapy, Chiropractic Care, Massage Therapy, TCM Acupuncture, Osteopathic Manual Therapy and Naturopathic Medicine. By offering a range of services under one roof, Choice Health Centre creates a seamless, integrated experience that allows patients to access individualized care plans that reflect their goals, health concerns, and lifestyle. "We believe healthcare should be tailored, empowering, and rooted in education," says Dr. Kempt-Sutherland, Founder of Choice Health Centre and Centre Director. "That's why we've built a team of professionals who can guide patients through every stage of their wellness journey." Supporting Informed, Proactive Health Decisions Choice Health Centre's approach is grounded in education and empowerment. Patients are equipped with the information and tools they need to make confident decisions about their care-whether they're recovering from injury, managing chronic conditions, or simply striving for a healthier way of life. "We want everyone who walks through our doors to feel informed, supported, and inspired to take an active role in their care," adds Dr. Kempt-Sutherland. "When patients are engaged and confident, real transformation is possible." Improving Community Wellness Across Nova Scotia Beyond individual care plans, the clinic is dedicated to helping their communities thrive by getting involved in community initiatives, advocating for patients and providing inclusive, accessible care to people of all ages and lifestyles. Serving everyone from families and seniors to athletes and professionals, Choice Health Centre has become a trusted destination for high quality collaborative health and wellness services in Halifax. Recognition Backed by Independent Research The Consumer Choice Award is the only organization in North America that recognizes business excellence through a four-step, independent research process. Conducted by a third-party research firm, this methodology involves gathering unbiased consumer feedback, analyzing brand reputation, and verifying top-ranked service providers in each local category. "This recognition reflects the relationships we've built with our patients and the shared commitment we have to helping our communities thrive," says Dr. Kempt-Sutherland. "We're proud to be part of a growing movement toward collaborative, person-centered care." To learn more about the Choice Health Centre or book an appointment, CLICK HERE or visit About Consumer Choice Award:Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit to learn more. Contact Information:Sumi SalehCommunications Managerssaleh@ SOURCE: Consumer Choice Award
Miami Herald
a day ago
- Miami Herald
Private Practices Are Being Squeezed by Med Spas and Hospital Systems, Dr. Meegan Gruber Warns Patients Must Put Safety First
Med spas together with hospital systems have started compressing private practices; Dr. Meegan Gruber urges patients to prioritize safety. TAMPA, FLORIDA / ACCESS Newswire / August 13, 2025 / Board-Certified Plastic Surgeon Dr. Meegan Gruber, MD, PhD, has launched an alert about the fast transformation of private practice ownership from physicians to large hospital systems and fast-growing med spas. The AMA conducted a benchmark survey which revealed that private practice physicians decreased from 60.1% in 2012 to 42.2% in 2024. Patients require ongoing medical care with personal physician supervision. The current market dynamics override medical expertise when it comes to determining both the delivery sites and methods of aesthetic care, according to Dr. Gruber. The medical landscape has transformed into a hospital and corporate employment-based structure -- a national analysis by the Physicians Advocacy Institute and Avalere found hospital and corporate employment rates reached 77.6% by January 2024. The same study indicates hospital employment increased to 55.1% while corporate employment reached 22.5% because of intense consolidation, which weakens patient-physician decision-making. Med spas have both proliferated in numbers and generated substantial revenue growth during the same period. Medical spas in the United States now operate above $17 billion annually while their market grows at a rate exceeding $1 billion yearly, according to the American Med Spa Association. The American Med Spa Association reports that the medical spa industry now generates $17 billion in revenue annually and adds $1 billion each year to its market value. New medical spa establishments increased by 18% during 2023, according to recent data. Medical standards that lack uniformity will produce inconsistent treatment results according to Dr. Gruber. Multiple states experienced hospitalizations because federal investigations revealed multiple cases of counterfeit botulinum toxin and mishandled injections in non-regulated medical settings. Price and convenience will never replace the importance of medical training and established protocols, according to Dr. Gruber. Patients should verify the identity of the procedure performer and the supervising physician's board certification and confirm emergency readiness at the facility. She suggests patients check for ABMS-recognized board certification in plastic surgery and insist on meeting the surgeon personally and verify where they source injectables. Dr. Gruber provides awake surgery under local anesthesia to qualified candidates as an option that reduces general anesthesia exposure and enables real-time team communication. She stated that the patient needs to be the correct choice while the procedure needs to be appropriate for the patient and the treatment must occur in an appropriate environment. At Gruber Plastic Surgery patients can discover more information about physician-led care that maintains continuity and learn about awake surgery and schedule a safety oriented consultation by contacting us. About Gruber Plastic Surgery Gruber Plastic Surgery, located in Tampa, FL, is led by Dr. Meegan Gruber, Ph.D., board-certified plastic surgeon renowned for her pioneering work in awake plastic surgery. Dr. Gruber, also the star of "Awake Surgery," which you can stream today on TLC GO, HBO MAX, Hulu, Discovery+, and other streaming platforms, integrates advanced techniques and cutting-edge technology to deliver safe, comfortable, and natural-looking results with minimized recovery time. Specializing in awake surgeries, the clinic offers a range of state-of-the-art procedures. Dr. Gruber is committed to innovation and education, ensuring precision and safety in every treatment, while enhancing patient confidence through individualized care and surgical expertise. Contact Information Jay Saint info@
